Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 7.96286 | 93 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 4.71278 | 73 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 6.42398 | 85 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 9.45558 | 97 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 8.58895 | 95 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 7.21494 | 91 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 8.28764 | 95 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 9.6177 | 98 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 10.218 | 98 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 10.6211 | 98 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 6.21526 | 84 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 9.1168 | 96 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 8.43809 | 95 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 8.41826 | 95 |